Jill Feldman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ST. LOUIS - FleishmanHillard has bolstered its cybersecurity leadership with the return of Apple's Scott Radcliffe as global director of cybersecurit

When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary. Crosslin

For cancer patients, the harsh side effects of powerful drugs have long been the trade-off for living longer. Now, patients and officials are pushing drugmakers to study lower doses early in the research process.

For cancer patients, the harsh side effects of powerful drugs have long been the trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary.

Cancer patients and doctors have ignited a movement to radically change how new cancer drugs are tested to make them more tolerable. Harsh side effects from powerful cancer drugs have long been accepted as a trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary. The U.S. Food and Drug Administration is pushing drugmakers to do a better job at finding the lowest effective dose, even if it takes more time. One group is planning a study to test whether lower doses of two new drugs will work for breast cancer that has spread.